KZIAKAZIA THERAPEUTICS LTD

Nasdaq kaziatherapeutics.com


$ 0.36 $ 0.00 (-1.03 %)    

Wednesday, 21-Aug-2024 15:22:40 EDT
QQQ $ 482.88 $ 2.24 (0.47 %)
DIA $ 408.91 $ 0.43 (0.11 %)
SPY $ 560.81 $ 1.92 (0.34 %)
TLT $ 98.72 $ 0.06 (0.06 %)
GLD $ 232.16 $ -0.31 (-0.13 %)
$ 0.3662
$ 0.36 x 100
-- x --
-- - --
$ 0.19 - $ 1.58
341,806
na
8.35M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2006 11-06-2006 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-kazia-therapeutics-maintains-2-price-target

HC Wainwright & Co. analyst Sean Lee reiterates Kazia Therapeutics (NASDAQ:KZIA) with a Buy and maintains $2 price target.

 whats-going-on-with-kazia-therapeutics-shares-thursday

Kazia Therapeutics announced results from its Phase II/III trial in regards to the treatment of glioblastoma, a type of brain c...

 kazia-therapeutics-shares-are-jumping-today-successful-study-for-brain-cancer-treatment

Kazia Therapeutics reports a 33% improvement in overall survival for newly diagnosed glioblastoma patients using paxalisib in a...

 kazia-to-present-dipg-data-at-ispno-june-29---july-2

Kazia Therapeutics Limited (NASDAQ:KZIA), a biotechnology company specialising in oncology, is pleased to announce the presenta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION